Papers in BMJ
Page 7 · newest first
- Clinical updates: Assessment and management of suicidal ideation in adultsBMJ · 2026
- Bad influencers: How social media imported US-style drug advertising to the UKBMJ · 2026
- Valdo Calocane inquiry offers valuable lessons for overhauling mental health servicesBMJ · 2026
- Stereotactic radiotherapy for neovascular age related macular degeneration: year 3 and 4 extended follow up results of a randomised, double masked, sham controlled, device trial (STAR)BMJ · 2026
- Adapting health systems for water bankruptcyBMJ · 2026
- When I use a word . . . The Devil’s Medical DictionaryBMJ · 2026
- Detrimental effects of conflicts of interest in GLP-1 therapy guidanceBMJ · 2026
- Data sharing must evolve towards data sovereigntyBMJ · 2026
- Maximising the benefits of mandatory calorie menu labelling in EnglandBMJ · 2026
- Breaking down barriers to medical training - the resident doctor who helps students meet their potentialBMJ · 2026
- Obesity versus China: how Ozempic is complicating the world’s largest weight loss campaignBMJ · 2026
- Advances in the development of malaria vaccinesBMJ · 2026
- American Diabetes Association controversy: Activism is necessary to protect scientific freedomBMJ · 2026
- Why not screening for prostate cancer is justifiedBMJ · 2026
- UK Biobank: Confidential patient health details still online three months after leaks, BMJ findsBMJ · 2026
- Fitness to practice tribunals for sexual misconduct are unfit for purposeBMJ · 2026
- Reporting of Cohort and Routinely Collected Data in Randomised Controlled Trial Protocols (SPIRIT-ROUTINE): extension checklist with explanation and elaborationBMJ · 2026
- Updated International Patient Decision Aid Standards (IPDAS version 5.0): modified Delphi, evidence informed consensus processBMJ · 2026
- Influence on regulatory decisions for drugs with limited evidenceBMJ · 2026
- Ditching the smartphone: how one GP swapped doom scrolling for improved focus and productivityBMJ · 2026
- Prisons: A missing front in England’s HIV action planBMJ · 2026
- The limits of reporting checklists in paediatric researchBMJ · 2026
- Low concentration atropine eye drops and progression of myopia in children: multicentre placebo controlled, double masked, randomised trial in the UK (CHAMP-UK)BMJ · 2026
- Trump's gold standard science is harming US science and healthBMJ · 2026
- A London Lark Rising : the story of the people and places of the East India CompanyBMJ · 2026
- Rammya Mathew: The sleep fairy scandal is a wake-up call for public healthBMJ · 2026
- Nicotine as a wellness product? The smoking alternatives being pushed by big tobaccoBMJ · 2026
- Advances in supporting development in autistic children and youthBMJ · 2026
- DRC has strengthened its response to Ebola - but conflict and funding cuts are testing its capacityBMJ · 2026
- Nottingham attacks inquiry: what we learnt, and what families want nextBMJ · 2026
- What Your Patient is Thinking: Compassion on the journey to a dementia diagnosisBMJ · 2026
- My colleague made a derogatory comment about a patient - what now?BMJ · 2026
- AI warfare demands a new era of humanitarian lawBMJ · 2026
- Middle powers must collaborate on health data and health AI is imperativeBMJ · 2026
- The peace pill: an overdue prescription for the Eastern Mediterranean RegionBMJ · 2026
- Advances in the management of ADHD in children and adolescentsBMJ · 2026
- Will AI do more harm than good to the UK's mental health?BMJ · 2026
- Improving ADHD care pathways should be prioritised for children and young peopleBMJ · 2026
- After remarkable progress, newborn, child, and adolescent survival is now at riskBMJ · 2026
- Systematic estimates of global causes of neonatal and under 5 mortality in 2000-24: secondary data analysis using bayesian multinomial logistic regressionBMJ · 2026
- Estimates of global causes of death for children and adolescents aged 5-19 in 2000-24: secondary data analysis using bayesian multinomial logistic regressionBMJ · 2026
- Global, regional, and national levels and trends in under 5, infant, and neonatal mortality during 1990-2024 with scenario based projections to 2030: modelling studyBMJ · 2026
- Global, regional, and national levels and trends in older child, adolescent, and youth (5-24 years) all cause mortality from 1990 to 2024: modelling studyBMJ · 2026
- Designer peptides for wellness: are they safe?BMJ · 2026
- Six ways Gavi will continue to immunise half the world's children amid vaccine backlash and a funding crisisBMJ · 2026
- Using routinely collected data for research purposes: challenges and mitigation strategiesBMJ · 2026
- Satisfaction with the NHS is rising—so why are people still so unhappy with it?BMJ · 2026
- Helen Salisbury: Goodbye, Mr StreetingBMJ · 2026
- UK National Screening Committee position statement on surrogate outcomes in cancer screening trialsBMJ · 2026
- Enhanced Games: Bold claims, weak evidence, and serious risksBMJ · 2026